Correction: Loss of CDYL results in suppression of CTNNB1 and decreased endometrial receptivity
Xiaowei Zhou, Bufang Xu, Dan Zhang, Xiaoping Jiang, Hsun-Ming Chang, Peter C. K. Leung, Xiaoyu Xia, Aijun Zhang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEstrogen and related hormone effects
In the published article, there was an error in Figure 3C. The authors have identified that the image for the CDYL-sh1 48h treatment was inadvertently duplicated from the CDYL-sh3 24h treatment due to an error during figure preparation. The corrected Figure 3C and its caption appear below.
In the published article, there was an error in Figure 5F. Although the Western blot for CDYL in Figure 5F was performed on the same experimental day, it was not run on the same membrane as CTNNB1 and GAPDH, due to an error during figure preparation. The corrected Figure 5F and its caption appear below.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.